Document is current
Any future updates will be listed below
-
Authors
Zheng, Chunwei https://orcid.org/0000-0002-2084-5567
Zhang, Gangming https://orcid.org/0000-0002-8488-2607
Dean, Lilia J. https://orcid.org/0009-0001-2225-6395
Sontheimer, Erik J. https://orcid.org/0000-0002-0881-0310
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01GM150279, P01HL158506, UH3HL147367)
Friedreich's Ataxia Research Alliance
Cystic Fibrosis Foundation
- License Information
-
More Information
Article History
Received: 23 June 2024
Accepted: 17 January 2025
First Online: 17 February 2025
Competing interests
: E.J.S. is a cofounder and scientific advisor of Intellia Therapeutics and a Scientific Advisory Board member at Tessera Therapeutics. The other authors declare no competing interests.
